When should an alternative agent to vancomycin be considered for MRSA infections?
from Let's Talk MRSA: 20 Frequently Asked Questions Hosted by Vemco MedEd
In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
When was this Let's Talk MRSA: 20 Frequently Asked Questions episode published?
This episode was published on November 21, 2010.
Can I download this Let's Talk MRSA: 20 Frequently Asked Questions episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.